acquisition
AstraZeneca acquires biotech’s unique antithrombotic drug
January 5, 2017Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition
AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …
Allergan shells out $2.9bn for regenerative medicine unit LifeCell
December 21, 2016Research and Development, Sales and Marketing Allergan, LifeCell, acquisition
Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …
Looking back at the biggest deal of 2016: Bayer-Monsanto
December 2, 2016Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016
The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …
J&J reportedly poised to acquire Europe’s biggest biotech
November 25, 2016Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition
Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …
Abbott-St. Jude $25 billion deal close to clearance
November 16, 2016Research and Development, Sales and Marketing Abbott, St. Jude, acquisition
EU antitrust regulators are due to reach a decision on the deal on 23 November that would see Abbott Laboratories …
ICU Medical to acquire Pfizer’s global infusion therapy business in $1 billion deal
October 6, 2016Medical Communications Hospira, ICU medical, Pfizer, acquisition, infusion
The $1 billion deal that will take place as ICU Medical Inc. take over Pfizer’s Hospira Infusion Systems will be …
$600m acquisition bolsters Celgene’s blood cancer portfolio
October 3, 2016Manufacturing and Production, Research and Development Celgene, EngMab, acquisition, lymphoma, multiple myeloma
Celgene has shelled out $600m for Swiss biotech EngMab in an effort to reinforce its blood cancer portfolio with a …
J&J in $4.33bn eye surgery unit acquisition
September 19, 2016Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition
Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …
Dechra signs £31 million acquisition
September 16, 2016Medical Communications Apex Laboratories, Dechra, acquisition
Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …
Allergan snaps up Vitae Pharma for $639 million
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition
Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
Horizon buys out Raptor for $800 million
September 13, 2016Manufacturing and Production, Sales and Marketing Horizon Pharma, Raptor Pharmaceutical, acquisition
Irish biopharmaceutical firm Horizon Pharma has finalised an $800 million deal to buy Raptor Pharmaceutical Corp in a bid to …
Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition
September 12, 2016Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto
In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …
Allergan acquires biotech Retrosense for $60 million
September 7, 2016Research and Development, Sales and Marketing Allergan, Retrosense, acquisition
Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …
Pfizer acquires Medivation for $14 billion
August 22, 2016Sales and Marketing Medivation, Pfizer, acquisition, oncology
Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …
Allergan set to acquire eye-care biotech ForSight VISION5
August 12, 2016Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care
Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
